$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said metho 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/44
  • A61K-031/78
  • A61F-013/02
출원번호 US-0188226 (1988-04-29)
우선권정보 IE-0001119 (1987-05-01); IE-0001946 (1987-07-17)
발명자 / 주소
  • Bannon Yvonne B. (Naas IEX) Corish John (Leopardstown IEX) Corrigan Owen I. (Howth IEX) Geoghegan Edward J. (Athlone IEX) Masterson Joseph G. (Dublin IEX)
출원인 / 주소
  • Elan Transdermal Limited (Athlone IEX 03)
인용정보 피인용 횟수 : 47  인용 특허 : 3

초록

A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of n

대표청구항

A preparation for the once-daily, percutaneous administration of nicotine which comprises nicotine uniformly distributed in a solid or semi-solid medium which can be placed in intimate contact with the skin, said solid or semi-solid medium comprising a given amount of nicotine in a solution of a sol

이 특허에 인용된 특허 (3)

  1. Leeson Lewis J. (Roseland NJ), Devices and methods for treating memory impairment.
  2. Hymes Alan C. (Minnetonka MN) Ong Lincoln T. (Minnetonka MN) Persons Garry R. (Edina MN), Drug dispensing device for transdermal delivery of medicaments.
  3. Etscorn Frank T. (121 Stallion Cir. Socorro NM 87801), Transcutaneous application of nicotine.

이 특허를 인용한 특허 (47)

  1. Glenn,Gregory M.; Alving,Carl R., Adjuvant for transcutaneous immunization.
  2. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  3. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  4. Lee Eun Soo (Redwood City CA) Yum Su Il (Los Altos CA) Cormier Michel J. N. (Mountain View CA), Formulations with hydrophobic permeation enhancers.
  5. Chau, Tommy L.; Pinney, John M.; Henningfield, Jack E.; Cone, Edward J.; Shiffman, Saul M.; Gitchell, Joseph G., Medicinal delivery system, and related methods.
  6. Baker Richard W. (Palo Alto CA) Santus Giancarlo (Milan ITX) Vintilla-Friedman Susan (Cupertino CA), Method and therapeutic system for smoking cessation.
  7. Zawadzki, Waldemar; Johannison, Ulf, Method for perforating heat meltable material.
  8. Osborne James L. (2365 Thompson Ct. Mountain View CA 94043) Nelson Melinda K. (1127 Hollenbeck Sunnyvale CA 94087) Enscore David J. (18291 Montpere Way Saratoga CA 95070) Yum Su I. (1021 Runnymead Ct, Method of administering nicotine transdermally.
  9. Blight, Andrew R.; Cohen, Ron, Method of using sustained release aminopyridine compositions.
  10. Blight, Andrew R.; Cohen, Ron, Methods of using sustained release aminopyridine compositions.
  11. Blight, Andrew R.; Cohen, Ron, Methods of using sustained release aminopyridine compositions.
  12. Cooke, John; Jang, James; Tsao, Phillip; Heeschen, Christopher, Nicotine in therapeutic angiogenesis and vasculogenesis.
  13. Cooke, John; Jang, James; Tsao, Phillip; Heeschen, Christopher, Nicotine in therapeutic angiogenesis and vasculogenesis.
  14. Santus Gian Carlo,ITX, Nicotine lozenge.
  15. Santus Gian Carlo (Milan ITX), Nicotine lozenge and therapeutic method for smoking cessation.
  16. Keenan Robert M., Nicotine metabolites and human body weight.
  17. Keenan Robert M., Nicotine metabolites and nicotine dependence.
  18. Satoda, Shiro; Ninomiya, Kazuhisa; Saito, Junichi; Matsuoka, Kensuke; Kikuchi, Shunetsu, Nicotine transdermal preparation and production method thereof.
  19. Mori, Tatsuya; Saida, Naoyuki, Non-aqueous patch.
  20. Mori, Tatsuya; Saida, Naoyuki, Non-aqueous patch.
  21. Mori, Tatsuya; Saida, Naoyuki, Non-aqueous patch.
  22. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  23. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  24. Cody Mary E., Plantago major transdermal patch for use in treating a tobacco or nicotine habit.
  25. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  26. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  27. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  28. Masiz, John J.; Carter, Stephen G., Solution-based transdermal drug delivery system.
  29. Blight, Andrew R.; Cohen, Ron, Sustained release aminopyridine composition.
  30. Blight, Andrew R.; Cohen, Ron, Sustained release aminopyridine composition.
  31. Blight, Andrew R.; Cohen, Ron, Sustained release aminopyridine composition.
  32. Blight, Andrew R.; Cohen, Ron, Sustained release aminopyridine composition.
  33. Keenan Robert M. (Baltimore MD) Hatsukami Dorothy K. (Golden Valley MN), Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine.
  34. Glenn, Gregory M.; Alving, Carl R., Transcutaneous immunization without heterologous adjuvant.
  35. Barnhart Scott D. ; Mariani Elio P., Transdermal delivery of active drugs.
  36. Keenan Robert M., Transdermal nicotine metabolites and human body weight.
  37. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  38. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  39. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  40. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  41. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  42. Pinney, John M.; Henningfield, Jack E.; Shiffman, Saul; Gitchell, Joseph; Cone, Edward J., Two-stage transmucosal medicine delivery system for symptom relief.
  43. Rolf David, Use of cotinine in treating psychiatric disorders.
  44. Rolf David, Use of cotinine in treating psychiatric disorders.
  45. Glenn, Gregory M.; Alving, Carl R., Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response.
  46. Glenn,Gregory M.; Alving,Carl R., Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant.
  47. Glenn, Gregory M.; Cassels, Frederick J., Vaccine for transcutaneous immunization.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로